Search
Sumario de resultados
TIpos de contenido
Fecha
-
-
NewMineralys Therapeutics Closes $118 Million Oversubscribed Series B Financing to Advance th...
Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors
-
NewGENESIS Biomed receives the award for the best biomedical consultancy in the XI Edition of...
Last May 19th GENESIS Biomed received the award to the best biomedical consultancy of the XI Edition of the National Awards El Suplemento
-
NewLife Length obtains European authorization for its innovative prostate cancer diagnostic ...
PROSTAV® tiene por objeto mejorar sustancialmente el diagnóstico de cáncer de próstata; el más frecuente en los hombres que afectará hasta a 1 de cada 6 hombres a lo largo de sus vidas y que en España
-
NewORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Small...
Now has orphan drug designation for SCLC and AML
-
NewNatac opens new Singapore office to locally serve its APAC customers
Madrid, Wednesday, June 1st, 2022— Natac has opened an office in central Singapore, to expand its sales, logistics and commercial operations into the Asia Pacific region. Natac who are headquartered
-
NewVesismin creates pioneering programme with comprehensive approach to hospital infections
Vesismin offers hospitals and health centres Vesismin Services, the first comprehensive programme to provide a global, personalised approach to preventing and controlling healthcare-associated
-
Event#ForAseBioMembers | Meeting with international media
"Between war and pandemic: How Spanish biotech could answer to our biggest crisis as a society" is the name of the meeting organised by AseBio with its partners and international s
-
NewORYZON awarded EU Seal of Excellence and public financing of 2 M USD to develop iadademsta...
Non-refundable funds from the Next Generation-EU program
-
Press releaseBiotechnology positioned as a strategic tool to promote sustainable agrifood
AseBio partners develop almost 200 products to improve the agrifood system and protect the planet in a context of great challenges. In 2021, Spanish biotechnology companies attracted 14% of the
-
Press releaseAseBio and MNCN-CSIC bring together nearly 1,000 people to raise awareness of role science...
This 2022 Environment Week also falls under the framework of the European Climate Pact, for which AseBio is the national coordinator and has over 130 ambassadors Over 100 biotechnology companies are
-
NewAseBio and MNCN-CSIC bring together nearly 1,000 people to raise awareness of role science...
This 2022 Environment Week also falls under the framework of the European Climate Pact, for which AseBio is the national coordinator and has over 130 ambassadors Over 100 biotechnology companies are
-
NewORYZON to give updates on corporate progress in June
Oryzon Genomics, S.A, announced today that its management will give an update on corporate progress at several international events in June
-
NewWhy Not Next Generation Sequencing?
16 June 2022, 13:00-14:00 CET Next generation sequencing has forever changed how we study life, health and disease. Just like the mobile phone evolved into a multifunctional device, NGS took over from
-
NewKimitec publishes its new products for the month of May
Kimitec is a company dedicated to research and development in the field of crop bioprotection and microbiological nutrition
-
NewBIOLAN receives a new recognition for its innovate analytical digitalization solution at F...
BIOLAN was a finalist in the Agrobank Award, which recognizes the most innovative digitalisation solution, for its new generation of digitalised analysis equipment connected to the BIOLANglobal
-
NewCeltarys Research will present its technology for optimizing drug discovery at the XX Nati...
With the title of "From early discovery to translational medicinal chemistry" the next meeting of the Spanish Society of Medicinal Chemistry (SEQT) will be held in Santiago de Compostela from 19-22
-
NewBCN HEALTH publishes a study evaluating the hospital incidence and medical costs of chroni...
BCN HEALTH has published the study ‘Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs’ in the journal ‘Expert Review of
-
NewCrowdfunding and Venture Capital: two complementary systems for private funding in the hea...
Private funding, and in this case non-bank funding, is the main funding alternative for most business projects and Venture Capital is the main vehicle for this
-
AllyRENTA 4 BANK
Our mission and commitment is to give savers, families and companies the best solutions for their investment needs, incorporating education into our work as managers and advisers, and making available
-
CompanyAFFIRMA BIOTECH